Natco Gets US Front-End Through Dash Acquisition
Indian Firm’s $18m Deal For US Company Represents Potential Strategy Shift
India’s Natco Pharma has struck an $18m deal to acquire New Jersey-based Dash Pharmaceuticals in a bid to acquire a “direct front-end marketing footprint” in the US.
